ADVANTAGENE INC has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are VIANEX S A, RATH MATTHIAS W and MORPHOGENESIS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Canada | 1 | |
#3 | China | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Israel | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Animal care | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Guzik Brian | 6 |
#2 | Aguilar-Cordova Estuardo | 5 |
#3 | Lawler Sean | 5 |
#4 | Speranza Maria Carmella | 5 |
#5 | Chiocca Antonio E | 5 |
#6 | Aguilar Laura Kaye | 5 |
#7 | Maria Carmella Speranza | 1 |
#8 | Estuardo Carlos | 1 |
#9 | Estuardo Aguilar-Cordva | 1 |
#10 | Aguilar-Cordova Carlos Estuard | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020172671A1 | Gmci and ddri combination therapy for treating cancer | |
US2019216903A1 | Methods of cytotoxic gene therapy to treat tumors | |
KR20190059304A | How to cure TIM-3 elevation | |
WO2009006300A2 | Production cell lines for adenoviral manufacturing | |
WO2005049094A1 | A mixed complementary viral vector for gene therapy |